全文获取类型
收费全文 | 10134篇 |
免费 | 800篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 145篇 |
儿科学 | 196篇 |
妇产科学 | 151篇 |
基础医学 | 1174篇 |
口腔科学 | 105篇 |
临床医学 | 1062篇 |
内科学 | 2147篇 |
皮肤病学 | 128篇 |
神经病学 | 845篇 |
特种医学 | 378篇 |
外科学 | 2072篇 |
综合类 | 125篇 |
一般理论 | 11篇 |
预防医学 | 812篇 |
眼科学 | 228篇 |
药学 | 616篇 |
中国医学 | 12篇 |
肿瘤学 | 767篇 |
出版年
2024年 | 15篇 |
2023年 | 151篇 |
2022年 | 225篇 |
2021年 | 585篇 |
2020年 | 299篇 |
2019年 | 487篇 |
2018年 | 544篇 |
2017年 | 361篇 |
2016年 | 366篇 |
2015年 | 395篇 |
2014年 | 554篇 |
2013年 | 653篇 |
2012年 | 977篇 |
2011年 | 903篇 |
2010年 | 503篇 |
2009年 | 401篇 |
2008年 | 595篇 |
2007年 | 583篇 |
2006年 | 510篇 |
2005年 | 468篇 |
2004年 | 405篇 |
2003年 | 345篇 |
2002年 | 248篇 |
2001年 | 36篇 |
2000年 | 17篇 |
1999年 | 32篇 |
1998年 | 37篇 |
1997年 | 31篇 |
1996年 | 28篇 |
1995年 | 21篇 |
1994年 | 18篇 |
1993年 | 19篇 |
1992年 | 13篇 |
1991年 | 12篇 |
1990年 | 16篇 |
1989年 | 6篇 |
1988年 | 7篇 |
1987年 | 6篇 |
1986年 | 8篇 |
1985年 | 5篇 |
1984年 | 7篇 |
1983年 | 12篇 |
1982年 | 6篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1976年 | 9篇 |
1972年 | 3篇 |
1963年 | 3篇 |
1955年 | 3篇 |
1954年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
111.
112.
113.
114.
115.
Oded Volovelsky Gili Cohen Ariel Kenig Gilad Wasserman Avigail Dreazen Oded Meyuhas Justin Silver Tally Naveh-Many 《Journal of the American Society of Nephrology : JASN》2016,27(4):1091-1101
Secondary hyperparathyroidism is characterized by increased serum parathyroid hormone (PTH) level and parathyroid cell proliferation. However, the molecular pathways mediating the increased parathyroid cell proliferation remain undefined. Here, we found that the mTOR pathway was activated in the parathyroid of rats with secondary hyperparathyroidism induced by either chronic hypocalcemia or uremia, which was measured by increased phosphorylation of ribosomal protein S6 (rpS6), a downstream target of the mTOR pathway. This activation correlated with increased parathyroid cell proliferation. Inhibition of mTOR complex 1 by rapamycin decreased or prevented parathyroid cell proliferation in secondary hyperparathyroidism rats and in vitro in uremic rat parathyroid glands in organ culture. Knockin rpS6p−/− mice, in which rpS6 cannot be phosphorylated because of substitution of all five phosphorylatable serines with alanines, had impaired PTH secretion after experimental uremia- or folic acid–induced AKI. Uremic rpS6p−/− mice had no increase in parathyroid cell proliferation compared with a marked increase in uremic wild–type mice. These results underscore the importance of mTOR activation and rpS6 phosphorylation for the pathogenesis of secondary hyperparathyroidism and indicate that mTORC1 is a significant regulator of parathyroid cell proliferation through rpS6. 相似文献
116.
Xinhai Zhang Sonia Kelaria Justin Kerstetter Jun Wang 《Journal of gastrointestinal oncology.》2015,6(3):307-313
One of the cornerstones for the immune system is the discovery of T-regulatory cells (Treg), which play an essential role in maintaining self regulation of the immune response to foreign threats. However, they may also interfere with the immune response to tumoral cells, for which reason much effort has been put into characterizing the molecular makeup of this T cell population. It has been shown that Tregs are increased in the peripheral blood of patients with many cancer types, and also enriched in the tumor sites. However, the significance of this phenomenon on prognosis is controversial, especially in colorectal carcinoma, one of the most common cancers worldwide and a major cause of cancer-related death. This literature review focuses on characterization of the Treg cells in colorectal cancer patients and its implications on the prognosis of this disease. In the end, the potential therapeutic strategies aimed at Treg modification are discussed. 相似文献
117.
118.
119.
120.
Elizabeth S. Gabitzsch Kwong Yok Tsang Claudia Palena Justin M. David Massimo Fantini Anna Kwilas Adrian E. Rice Yvette Latchman James W. Hodge James L. Gulley Ravi A. Madan Christopher R. Heery Joseph P. Balint Jr. Frank R. Jones Jeffrey Schlom 《Oncotarget》2015,6(31):31344-31359
Phenotypic heterogeneity of human carcinoma lesions, including heterogeneity in expression of tumor-associated antigens (TAAs), is a well-established phenomenon. Carcinoembryonic antigen (CEA), MUC1, and brachyury are diverse TAAs, each of which is expressed on a wide range of human tumors. We have previously reported on a novel adenovirus serotype 5 (Ad5) vector gene delivery platform (Ad5 [E1-, E2b-]) in which regions of the early 1 (E1), early 2 (E2b), and early 3 (E3) genes have been deleted. The unique deletions in this platform result in a dramatic decrease in late gene expression, leading to a marked reduction in host immune response to the vector. Ad5 [E1-, E2b-]-CEA vaccine (ETBX-011) has been employed in clinical studies as an active vaccine to induce immune responses to CEA in metastatic colorectal cancer patients. We report here the development of novel recombinant Ad5 [E1-, E2b-]-brachyury and-MUC1 vaccine constructs, each capable of activating antigen-specific human T cells in vitro and inducing antigen-specific CD4+ and CD8+ T cells in vaccinated mice. We also describe the use of a combination of the three vaccines (designated Tri-Ad5) of Ad5 [E1-, E2b-]-CEA, Ad5 [E1-, E2b-]-brachyury and Ad5 [E1-, E2b-]-MUC1, and demonstrate that there is minimal to no “antigenic competition” in in vitro studies of human dendritic cells, or in murine vaccination studies. The studies reported herein support the rationale for the application of Tri-Ad5 as a therapeutic modality to induce immune responses to a diverse range of human TAAs for potential clinical studies. 相似文献